Hepatitis C virus diversity and hepatic steatosis

Journal of Viral Hepatitis

Volumn 20, Issue 2, 2013, Pages 77-84

  Roingeard, P ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

genotype; hepatic steatosis; hepatitis C virus; lipid droplet

Indexed keywords

MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; REACTIVE OXYGEN METABOLITE; STEROL REGULATORY ELEMENT BINDING PROTEIN;

AMINO ACID SEQUENCE; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; FATTY LIVER; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; INSULIN RESISTANCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS;

ANIMALS; FATTY LIVER; GENES, VIRAL; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INSULIN RESISTANCE; LIVER;

EID: 84872138890     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12035     Document Type: Review

References (62)

1. Cammà C, Bruno S, Di Marco V, et al,. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 2006; 43: 64-71. (Pubitemid 43738959)
2. Moucari R, Asselah T, Cazals-Hatem D, et al,. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008; 134: 416-423. (Pubitemid 351181308)
3. Vanni E, Abate ML, Gentilcore E, et al,. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. Hepatology 2009; 50: 697-706.
4. Milner KL, van der Poorten D, Trenell M, et al,. Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance. Gastroenterology 2010; 138: 932-941.
5. Cross TJ, Rashid MM, Berry PA, Harrison PM,. The importance of steatosis in chronic hepatitis C infection and its management. Hepatol Res 2010; 40: 237-247.
6. Rubbia-Brandt L, Quadri R, Abid K, et al,. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000; 33: 106-115. (Pubitemid 30418941)
7. Castera L, Hezode C, Roudot-Thoraval F, et al,. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis. Gut 2004; 53: 420-424. (Pubitemid 38241341)
8. Abid K, Pazienza V, de Gottardi A, et al,. An in vitro model of hepatitis C virus genotype 3a-associated triglyceride accumulation. J Hepatol 2005; 42: 744-751.
9. Hourioux C, Patient R, Morin A, et al,. The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. Gut 2007; 56: 1302-1308. (Pubitemid 47300434)
10. Jhaveri R, McHutchison J, Patel K, Qiang G, Diehl AM,. Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation. J Infect Dis 2008; 197: 283-291. (Pubitemid 351263449)
11. Hourioux C, Ait-Goughoulte M, Patient R, et al,. Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane. Cell Microbiol 2007; 9: 1014-1027. (Pubitemid 46394911)
12. Depla M, Uzbekov R, Hourioux C, et al,. Ultrastructural and quantitative analysis of the lipid droplet clustering induced by hepatitis C virus core protein. Cell Mol Life Sci 2010; 67: 3151-3161.
13. Roingeard P, Depla M,. The birth and life of lipid droplets: learning from the hepatitis C virus. Biol Cell 2011; 103: 223-231.
14. Herker E, Harris C, Hernandez C, et al,. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 2010; 16: 1295-1298.
15. Harris C, Herker E, Farese RV, Ott M,. Hepatitis C virus core protein decreases lipid droplet turnover: a mechanism for core-induced steatosis. J Biol Chem 2011; 286: 42615-42625.
16. Miyanari Y, Atsuzawa K, Usuda N, et al,. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007; 9: 1089-1097. (Pubitemid 47338147)
17. Roingeard P, Hourioux C, Blanchard E, Prensier G,. Hepatitis C virus budding at lipid droplet-associated ER membrane visualized by 3D electron microscopy. Histochem Cell Biol 2008; 130: 561-566.
18. Roingeard P, Hourioux C,. Hepatitis C virus core protein, lipid droplets and steatosis. J Viral Hepat 2008; 15: 157-164. (Pubitemid 351143746)
19. Bartenschlager R, Penin F, Lohmann V, André P,. Assembly of infectious hepatitis C virus particles. Trends Microbiol 2011; 19: 95-103.
20. Perlemuter G, Sabile A, Letteron P, et al,. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002; 16: 185-194. (Pubitemid 34113012)
21. Domitrovich AM, Felmlee DJ, Siddiqui A,. Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion. J Biol Chem 2005; 280: 39802-39808. (Pubitemid 41779113)
22. Siagris D, Christofidou M, Theocharis GJ, et al,. Serum lipid pattern in chronic hepatitis C: histological and virological correlations. J Viral Hepat 2006; 13: 56-61.
23. Mirandola S, Realdon S, Iqbal J, et al,. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 2006; 130: 1661-1669. (Pubitemid 43668848)
24. Dharancy S, Malapel M, Perlemuter G, et al,. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. Gastroenterology 2005; 128: 334-342. (Pubitemid 40431087)
25. de Gottardi A, Pazienza V, Pugnale P, et al,. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection. Aliment Pharmacol Ther 2006; 23: 107-114. (Pubitemid 43381173)
26. Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J,. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun 2007; 355: 883-888. (Pubitemid 46366910)
27. Jackel-Cram C, Babiuk LA, Liu Q,. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core. J Hepatol 2007; 46: 985-987.
28. Ryan MC, Desmond PV, Slavin JL, Congiu M,. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver. J Viral Hepat 2011; 18: 53-60.
29. Waris G, Felmlee DJ, Negro F, Siddiqui A,. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 2007; 81: 8122-8130. (Pubitemid 47101498)
30. Oem JK, Jackel-Cram C, Li YP, et al,. Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. J Gen Virol 2008; 89: 1225-1230.
31. Korenaga M, Wang T, Li Y, et al,. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005; 280: 37481-37488. (Pubitemid 41642356)
32. Okuda M, Li K, Beard MR, et al,. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122: 366-375. (Pubitemid 34116988)
33. Clément S, Peyrou M, Sanchez-Pareja A, et al,. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets. Hepatology 2011; 54: 38-49.
34. Kaddai V, Negro F,. Current understanding of insulin resistance in hepatitis C. Expert Rev Gastroenterol Hepatol 2011; 5: 503-516.
35. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL,. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-599.
36. Bugianesi E, Salamone F, Negro F,. The interaction of metabolic factors with HCV infection: does it matter? J Hepatol 2012; 56: S56-S65.
37. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ,. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115: 1343-1351. (Pubitemid 40629054)
38. Cornier MA, Dabelea D, Hernandez TL, et al,. The metabolic syndrome. Endocr Rev 2008; 29: 777-822.
39. Hui JM, Sud A, Farrell GC, et al,. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003; 125: 1695-1704. (Pubitemid 37500434)
40. Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L,. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005; 54: 1003-1008. (Pubitemid 40873917)
41. Barba G, Harper F, Harada T, et al,. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 1997; 94: 1200-1205. (Pubitemid 27087828)
42. Moriya K, Yotsuyanagi H, Shintani Y, et al,. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997; 78: 1527-1531. (Pubitemid 27343089)
43. Piodi A, Chouteau P, Lerat H, Hézode C, Pawlotsky JM,. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis. Hepatology 2008; 48: 16-27. (Pubitemid 351975527)
44. Depla M, d'Alteroche L, Le Gouge A, et al,. Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis. PLoS ONE 2012; 7: e33749.
45. Gottwein JM, Scheel TK, Hoegh AM, et al,. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 2007; 133: 1614-1626. (Pubitemid 350029736)
46. Shavinskaya A, Boulant S, Penin F, McLauchlan J, Bartenschlager R,. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem 2007; 282: 37158-37169.
47. Masaki T, Suzuki R, Murakami K, et al,. Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 2008; 82: 7964-7976.
48. Kim K, Kim KH, Ha E, Park JY, Sakamoto N, Cheong J,. Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma. FEBS Lett 2009; 583: 2720-2726.
49. Wang AG, Lee DS, Moon HB, et al,. Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice. J Pathol 2009; 219: 253-262.
50. Cai T, Dufour J-F, Muellhaupt B, et al,. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. J Hepatol 2011; 55: 529-535.
51. Sookoian S, Castaño GO, Burgueño AL, Gianotti TF, Rosselli MS, Pirola CJ,. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 2009; 50: 2111-2116.
52. Sookoian S, Pirola CJ,. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011; 53: 1883-1894.
53. Mirandola S, Osterreicher CH, Marcolongo M, et al,. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C. Liver Int 2009; 29: 557-565.
54. Zampino R, Ingrosso D, Durante-Mangoni E, et al,. Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients. J Viral Hepat 2008; 15: 740-746.
55. Tillmann HL, Patel K, Muir AJ, et al,. Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C. J Hepatol 2011; 55: 1195-1200.
56. Clark PJ, Thompson AJ, Zhu Q, et al,. The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection. Dig Dis Sci 2012; Epub ahead of print
57. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, et al,. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171: 1607-1610.
58. Nalpas B, Thiers V, Pol S, et al,. Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 1992; 14: 381-384.
59. Verbaan H, Andersson K, Eriksson S,. Intravenous drug abuse-the major route of hepatitis C virus transmission among alcohol-dependent individuals? Scand J Gastroenterol 1993; 28: 714-718. (Pubitemid 23231994)
60. Otani K, Korenaga M, Beard MR, et al,. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005; 128: 96-107. (Pubitemid 40039962)
61. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F,. Steatosis in chronic hepatitis C: why does it really matter? Gut 2006; 55: 123-130. (Pubitemid 41820647)
62. Leandro G, Mangia A, Hui J, Fabris P, et al,. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006; 130: 1636-1642.